Skip to main content
HOWL
NASDAQ Life Sciences

RA Capital Sells Over $530K in Werewolf Therapeutics Shares, Reducing Stake to 7.5%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.354
Mkt Cap
$17.986M
52W Low
$0.338
52W High
$2.38
52W Position info
4.8% above low
Off High info
85% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HOWL is trading near its 52-week low of $0.338 (4.8% above the low).

Summary

Major institutional investor RA Capital Management sold over $530,000 of Werewolf Therapeutics stock, reducing its ownership to 7.5% amidst the company's financial challenges and strategic review.


Key Events · Ownership and Investor Activity · HOWL

  • Significant Stake Reduction

    RA Capital Management, L.P. and its affiliates sold 1,484,396 shares of Werewolf Therapeutics common stock between June 16 and June 22, 2026.

  • Over $530K in Sales

    The total value of these open market sales amounted to approximately $531,710, executed at average prices between $0.35 and $0.37 per share.

  • Ownership Reduced to 7.5%

    Following these transactions, RA Capital's beneficial ownership in Werewolf Therapeutics has decreased to 3,654,307 shares, representing 7.5% of the outstanding common stock.

  • Ongoing Institutional Distribution

    This sale continues a pattern of institutional investors reducing their positions, occurring while the company explores strategic alternatives and faces "going concern" doubts.


Analysis · HOWL · Life Sciences

RA Capital Management, a major institutional investor, has significantly reduced its stake in Werewolf Therapeutics by selling over $530,000 worth of shares in open market transactions. This ongoing distribution by a key investor, representing nearly 3% of the company's market cap and almost 29% of their prior holdings, adds to concerns given the company's previously disclosed "going concern" issues and exploration of strategic alternatives. The sales occurred while the stock trades near its 52-week low.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18M. The 52-week trading range was $0.34 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.9836
Real-time Price: $0.9899 info
Change: +$0.0063 (+0.64%) info
Market Cap: $48.108M info
HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.9899 info
Change: +$0.0199 (+2%) info
Market Cap: $48.108M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.9899 info
Change: -$0.0101 (-1%) info
Market Cap: $48.108M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $0.9899 info
Change: +$0.0093 (+0.95%) info
Market Cap: $48.108M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $0.9899 info
Change: +$0.0192 (+2%) info
Market Cap: $48.108M info